[1]Bottari G, Taccone FS, Moscatelli A.Hybrid blood purification strategy in pediatric septic shock[J].Crit Care, 2016, 20(1):366-366
[2]杨荣利, 陈秀凯, 王小亭, 刘大为.重症血液净化:从连续肾脏替代治疗到集成技术[J].中华医学杂志, 2013, 93(35):2769-2771
[3]Vanholder R, Biesen WV, Hoste E, Lameire N.Procon debate: Continuous versus intermittent dialysis for acute kidney injury: a never-ending story yet approaching the finish[J].Crit Care, 2011, 15(1):204-204
[4]张任, 李正东, 曾艳.血液净化方式和时机对防治脓毒症致急性肾损伤临床效果的影响[J].医学综述, 2016, 22(2):374-376
[5] 曾丽娟, 詹淑晖, 李艳, 方安琪, 胡海涛.SLED联合HP对脓毒症合并重症急性肾损伤患者炎性应激、血流动力学参数及肾功能的影响[J]., 2018, (2):169-172
[6] 汪一帆, 白祥琰, 艾芬, 李维, 桂峰, 刘振兴.不同血液净化方式治疗脓毒症致急性肾损伤的疗效对比[J].临床急诊杂志, 2017, (6):420-423
[7] 朱艳, 崔云, 张育才.连续性血液净化辅助救治儿童重症急性胰腺炎[J]., 2017, (5):338-342
[8]Premuzic V, Basic-Jukic N, Jelakovic B, Kes P.Differences in CVVH vsCVVHDF in the management of sepsis-induced acute kidney injury in critically ill patients[J].J Artif Organs, 2017, 20(4):326-334
[9]Yun Cui, Yu-Cai.Zhang, Yu-Lin.Kang, Yu-Qian.Ren, Hui-J. .High-Volume Hemofiltration in Critically Ill Patients With Secondary Hemophagocytic Lymphohistiocytosis/Macrophage Activation Syndrome: A Prospective Study in the PICU[J].Pediatr Crit Care Med, 2016, (10):e437-e443
[10]钟春.不同血液净化方式对糖尿病肾病患者脂肪因子、炎症因子的影响[J].海南医学院学报, 2016, 22(4):340-342
[11]Fertel BS, Nelson LS, Goldfarb DS.Extracorporeal removal techniques for the poisoned patient: a review for the intensivist[J].J Intensive Care Med, 2010, 25(35):139-148
[12] Li M, Sun J, Li J, et al.Clinical observation on the treatment of acute liver failure by combined non-biological artificial liver[J].Experimental & Therapeutic Medicine, 2016, 12(6):3873-3876
[13] 中华医学会感染病学分会肝衰竭与人工肝学组.非生物型人工肝治疗肝衰竭指南（2016年版）[J].中华临床感染病杂志, 2016, (2):97-103
[14] 朱光耀, 任玉倩, 崔云, 张育才.血浆置换联合血液滤过辅助救治剥脱性皮炎[J].中国小儿急救医学, 2017, 24(8):621-625
[15] Schaefer B, Ujszaszi A, Schaefer S, Heckert KH, Schaefer F, Schmitt CP.Safety and Efficacy of Tandem Hemodialysis and Plasma Exchange in Children[J].Clinical Journal of the American Society of Nephrology Cjasn, 2014, 9(9):1563-1563
[16] Maruccio G, Montanaro A, Schiavone P, et al.CPFA (coupled plasma filtration absorption) treatment of septic shock:A retrospective study of nine patients[J].G Ital Nefrol, 2012, 29(54):S149-S150
[17] Franchi M, Giacalone M, Traupe I, et al.Coupled plasma filtration adsorption improves hemodynamics in septic shock[J].J Crit Care, 2016, (33):100-105
[18] Hazzard I, Jones S, Quinn T.Coupled plasma haemofiltration filtration in severe sepsis: systematic review and meta-analysis[J].J R Army Med Corps, 2015, 1(Suppl 1): i17- i17
[19] Chihara S, Masuda Y, Tatsumi H, et al.Early induction of direct hemoperfusion with a polymyxin-B immobilized column is associated with amelioration of hemodynamic derangement and mortality in patients with septic shock[J].J Artif Organs, 2017, 20(1):1-5
[20] Tokumasu H, Watabe S, Tokumasu S.Effect of hemodiafiltration therapy in a low-birthweight infant with congenital sepsis[J].Pediatr Int, 2016, 58(3):237-240
[21] 黎代强.双重血浆分子吸附系统(DPMAS)治疗重型肝病新进展[J].中国医学工程, 2015, (8):198-198
[22] Kribben A, Gerken G, Haag S, et al.Effects of Fractionated Plasma Separation and Adsorption on Survival in Patients With Acute-on-Chronic Liver Failure[J].Gastroenterology, 2012, 142(4):782-789.e3.
[23] Tsipotis E, Shuja A, Jaber BL.Albumin Dialysis for Liver Failure: A Systematic Review[J].Adv Chronic Kidney Dis, 2015, 22(5):382-390
[24] Nakae H, Eguchi Y, Saotome T, et al.Multicenter Study of Plasma Diafiltration in Patients With Acute Liver Failure[J].Therapeutic Apheresis & Dialysis, 2010, 14(5):444-450
[25] Evenepoel P, Laleman W, Wilmer A, et al.Prometheus versus molecular adsorbents recirculating system: comparison of efficiency in two different liver detoxification devices[J].Artif Organs, 2010, 30(4):276-284
[26] Laleman W, Wilmer A, Evenepoel P, et al.Effect of the molecular adsorbent recirculating system and Prometheus devices on systemic haemodynamics and vasoactive agents in patients with acute-on-chronic alcoholic liver failure[J].Critical Care, 2006, 10(4):R108-R108
[27] Guo LM.The evaluation for principles and clinical application of combined artificial liver therapy[J].Zhonghua Gan Zang Bing Za Zhi, 2009, 17(5):326-326
[28]Ba?ares R, Nevens F, Larsen FS, et al.Extracorporeal albumin dialysis with the molecular adsorbent recirculating system in acute-on-chronic liver failure: the RELIEF trial[J].Hepatology, 2013, 57(3):1153-1162
[29] Saliba F, Camus C, Durand F, et al.Albumin dialysis with a noncell artificial liver support device in patients with acute liver failure: a randomized, controlled trial[J].Ann Intern Med, 2013, 159(8):522-531
[30] He GL, Feng L, Duan CY, et al.Meta-analysis of survival with the molecular adsorbent recirculating system for liver failure[J].International Journal of Clinical & Experimental Medicine, 2015, 8(10):17046-17054
[31] Al-Chalabi A, Matevossian E, von TA, et al.Evaluation of an ADVanced Organ Support (ADVOS) system in a two-hit porcine model of liver failure plus endotoxemia[J]., 2017, 5(1):31-31
[32] Huber W, Henschel B, Schmid R, Al-Chalabi A.First clinical experience in 14 patients treated with ADVOS: a study on feasibility, safety and efficacy of a new type of albumin dialysis[J]., 2017, 17(1):32-32
[33] Meloni C, Ghezzi PM, Cipriani S, et al.Hemodiafiltration with post-dilution reinfusion of the regenerated ultrafiltrate: a new on-line technique[J].Clin Nephrol, 2005, 63(2):106-112
[34] Winchester JF, Salsberg JA.Sorbents in the treatment of renal failure[J].Minerva Urol Nefrol, 2004, 56(3):215-221
[35] Gao XF, Li JD, Guo L, et al.Effect of Hybrid Blood Purification Treatment on Secondary Hyperparathyroidism for Maintenance Hemodialysis Patients. Blood Purif. 2018. 46(1): 19-26.[J].Minerva Urol Nefrol, 2004, 56(3):215-221
[36] Yamamoto S, Kazama JJ, Wakamatsu T, et al.Removal of uremic toxins by renal replacement therapies: a review of current progress and future perspectives[J].Renal Replacement Therapy, 2016, 2(1):1-8
[37] 张文阁, 李强, 张璐等.组合人工肾、血液透析滤过、高通量透析对尿毒症脑病患者中大分子毒素清除效果观察[J].陕西医学杂志, 2017, (07):905-908
[38] 黄小蝶, 詹锋, 吴智丹, 许莲雅, 刘颖.杂合式血液净化模式治疗慢性肾功能不全合并心力衰竭的效果观察[J].检验医学与临床, 2018, (11):1664-1667
[39] Wu CH, Yang YW, Hung SC, et al.Ketoanalogues supplementation decreases dialysis and mortality risk in patients with anemic advanced chronic kidney disease[J]., 2017, 12(5):e0176847-e0176847
[40] 蓝天座, 闵亚丽, 樊丰夷等.高通量透析联合不同频率血液灌流对维持性血液透析患者微炎症状态和钙磷代谢的影响[J].实用医院临床杂志, 2016, 13(3):50-53
[41] 林强康, 杨絮, 林岳, 陈新国.不同血液净化方案下重度急性有机磷农药中毒患者的心肌状况对比[J].中国生化药物杂志, 2017, (5):419-421
[42] Li C, Hu D, Xue W, et al.Treatment Outcome of Combined Continuous Venovenous Hemofiltration and Hemoperfusion in Acute Paraquat Poisoning: A Prospective Controlled Trial[J].Crit Care Med, 2018, 46(1):1-1
[43] Park S, Lee S, Park S, et al.Concurrent Hemoperfusion and Hemodialysis in Patients with Acute Pesticide Intoxication[J].Blood Purif, 2016, 42(4):329-336
[44] 冯云生, 李川, 陈恔等.血液透析与血液灌流对终末期糖尿病肾病患者胰岛素抵抗及血清炎症因子水平的影响[J].现代生物医学进展, 2016, 16(11):2081-2083
[45] Li J, Li D, Xu Y, Wang A, Xu C, Yu C.The optimal timing of hemoperfusion component in combined hemodialysis–hemoperfusion treatment for uremic toxins removal[J].Ren Fail, 2015, 37(1):103-107
[46] 葛敏, 陈涛, 张杰.心脏手术后重症右心衰竭早期应用连续性肾脏替代治疗的临床分析[J].中华临床医师杂志电子版, 2017, 06(7):198-199
[47] 张海涛, 刘楠, 杨戎等.持续血液净化结合控制性心脏减负荷治疗心血管术后严重急性左心衰[J].中国体外循环杂志, 2008, 6(4):213-216
[48] 杜奕奇, 李维勤, 毛恩强.中国急性胰腺炎多学科诊治（MDT）共识意见（草案）[J].中国实用内科杂志, 2015, 31(12):1004-1010
[49] 冯小萌, 王原.急性胰腺炎发病机制及治疗研究进展[J].世界最新医学信息文摘, 2017, (40):26-30
[50] 刘云峰, 高咏梅, 杨婕琳, 马琴琴, 韩树池, 王俊利.杂合式血液净化序贯治疗重症急性胰腺炎的疗效观察[J].河北医科大学学报, 2016, 37(8):953-956
[51] Rong QWSBFPCXLJZ.Successful Treatment of Crush Syndrome Complicated with Multiple Organ Dysfunction Syndrome Using Hybrid Continuous Renal Replacement Therapy[J].Blood Purif, 2009, (3):175-180
[52] Lee KC, Stadlbauer V, Jalan R.Extracorporeal Liver Support Devices for Listed Patients[J].Liver Transpl, 2016, 22(6):839-839
[53] Ba?ares R, Catalina MV, Vaquero J.Molecular adsorbent recirculating system and bioartificial devices for liver failure[J].Clin Liver Dis, 2014, 18(4):945-956
[54] Sipeki N, AntalSzalmas P, Lakatos PL, Papp M.Immune dysfunction in cirrhosis[J].World J Gastroenterol, 2014, 20(10):2564-2577
[55] 郭利民.肝衰竭人工肝治疗的个体化选择[J]., 2017, 10(2):113-118
[56] 熊墨龙, 熊云逢, 欧阳兵, 谢能文, 张晓青, 吴慧玲.胆红素吸附联合低容量血浆置换治疗重型肝炎的疗效及安全性评估[J].重庆医学, 2018, (7):923-925
[57]Nevens F, Laleman W.Artificial liver support devices as treatment option for liver failure[J].Best Practice & Research Clinical Gastroenterology, 2012, 26(1):17-26
[58]Demetriou AA, Brown RS, Busuttil RW, et al.Prospective,randomized,multicenter,controlled trial of a bioartificial liver in treating acute liver failure[J].Annals of surgery, 2004, 239(5):660-670
[59]Larsen FS, Schmidt LE, Bernsmeier C, et al.High-volume plasma exchange in patients with acute liver failure: An open randomised controlled trial[J].Journal of Hepatology, 2016, 64(1):69-78
